Latest breakthroughs in cancer research, treatment, and prevention
309 articles
Revolutionary immune therapies and drug combinations are transforming bladder cancer treatment, offering unprecedented survival outcomes.
Scientists discover how to unleash macrophages against cancer by targeting cellular checkpoints that normally protect tumors.
New combination strategies show promise for overcoming immune resistance in head and neck cancers through targeted biomarker approaches.
New targeted therapies and personalized treatments are transforming ovarian cancer care, offering hope for better outcomes and longer survival.
Specific gut microbes produce compounds that reprogram fat cells to enhance immune responses against cancer.
Researchers discover CXCR6+ T cells drive deadly myocarditis from immune checkpoint inhibitors and find potential treatment target.
Breakthrough targeted drugs and immunotherapies are now approved for early-stage lung cancer, dramatically improving treatment options.
Specific gut bacteria enhance anti-PD-1 cancer treatment by converting immune cells into powerful tumor fighters.
New research reveals how a liver protein helps tumors evade immune surveillance, opening doors for targeted cancer therapies.
Novel drug combination targets chemotherapy-resistant ovarian cancer cells and extends survival in preclinical models.
Harvard researchers demonstrate that activated macrophages can both trigger immune responses and infiltrate tumors directly.
Advanced biomarker combinations show 96% accuracy in detecting pancreatic cancer, significantly better than current standard tests.
